Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

PORTLAND, OR, UNITED STATES, February 7, 2025 /EINPresswire / -- The global ulcerative colitis (UC) market is ex ...

such as treatments for moderate to severe active ulcerative colitis, to reach broader customer bases, boost sales, and increase revenue. These treatments often involve medications and, in some ...

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) that causes inflammation in the colon and rectum. Doctors may need to try multiple medications to find the right treatment to ...

Ongoing research into ulcerative colitis continues to uncover new treatment options, therapies, and ways to improve patient outcomes. Advances in biologic treatments and personalized medicine hold ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Data presented at the 2025 Crohn's and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...

AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease and ulcerative colitis, is the company's latest step into the treatment of ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...